PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In a clinical study investigating genetic variants in the progression of NAFLD, the PNPLA3 and TM6SF2 mutations were shown to be significantly correlated with increased liver steatosis and fibrosis, confirming their role in disease progression.